MA49618A - Inhibiteurs de la mpo destinés à être utilisés en médecine - Google Patents

Inhibiteurs de la mpo destinés à être utilisés en médecine

Info

Publication number
MA49618A
MA49618A MA049618A MA49618A MA49618A MA 49618 A MA49618 A MA 49618A MA 049618 A MA049618 A MA 049618A MA 49618 A MA49618 A MA 49618A MA 49618 A MA49618 A MA 49618A
Authority
MA
Morocco
Prior art keywords
medicine
mpo inhibitors
mpo
inhibitors
Prior art date
Application number
MA049618A
Other languages
English (en)
Inventor
Hitesh Jayantilal Sanganee
Andrew Whittaker
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MA49618A publication Critical patent/MA49618A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA049618A 2017-07-17 2018-07-12 Inhibiteurs de la mpo destinés à être utilisés en médecine MA49618A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762533448P 2017-07-17 2017-07-17

Publications (1)

Publication Number Publication Date
MA49618A true MA49618A (fr) 2020-05-27

Family

ID=62904484

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049618A MA49618A (fr) 2017-07-17 2018-07-12 Inhibiteurs de la mpo destinés à être utilisés en médecine

Country Status (16)

Country Link
US (2) US11246870B2 (fr)
EP (1) EP3654983B1 (fr)
JP (1) JP7220193B2 (fr)
KR (1) KR102705858B1 (fr)
CN (1) CN110891572B (fr)
AU (1) AU2018304508B2 (fr)
BR (1) BR112019026270A2 (fr)
CA (1) CA3068910A1 (fr)
EA (1) EA202090266A1 (fr)
ES (1) ES2963315T3 (fr)
IL (1) IL272043B (fr)
MA (1) MA49618A (fr)
MY (1) MY200803A (fr)
SG (1) SG11202000086PA (fr)
WO (1) WO2019016074A1 (fr)
ZA (1) ZA202000904B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018304508B2 (en) 2017-07-17 2021-06-10 Astrazeneca Ab MPO inhibitors for use in medicine
CA3157260A1 (fr) * 2019-10-10 2021-04-15 Biohaven Therapeutics Ltd. Promedicaments d'inhibiteurs de la myeloperoxydase
CN115403584B (zh) * 2021-05-26 2024-04-02 长春金赛药业有限责任公司 2-硫代-2,3-二氢嘧啶-4-酮衍生物、药物组合物及其制备方法和应用
CN115969862A (zh) * 2023-01-09 2023-04-18 深圳市第二人民医院(深圳市转化医学研究院) 2-氨基乙基二苯硼酸酯在制备治疗白细胞精液症的药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2362101A (en) 2000-05-12 2001-11-14 Astrazeneca Ab Treatment of chronic obstructive pulmonary disease
SE0201193D0 (sv) * 2002-04-19 2002-04-19 Astrazeneca Ab Novel use
MY140748A (en) * 2004-12-06 2010-01-15 Astrazeneca Ab Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
CA2642008A1 (fr) 2005-07-05 2007-01-11 Fertility Technologies Pty Ltd Procedes et compositions pour augmenter les chances de grossesse
AR066936A1 (es) 2007-06-13 2009-09-23 Astrazeneca Ab 3 - (2r - tetrahidrofuril - metil) - 2 - tioxantina. composiciones farmaceuticas.
US20090054468A1 (en) 2007-08-23 2009-02-26 Astrazeneca Ab New Use 938
JP5757604B2 (ja) 2010-02-05 2015-07-29 ヒガシマル醤油株式会社 ミエロペルオキシダーゼ阻害剤
US9616063B2 (en) * 2014-12-01 2017-04-11 Astrazeneca Ab 1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidase
US11241406B2 (en) 2015-08-28 2022-02-08 Nature's Sunshine Products, Inc. Compositions and methods for acutley raising nitric oxide levels
AU2018304508B2 (en) 2017-07-17 2021-06-10 Astrazeneca Ab MPO inhibitors for use in medicine

Also Published As

Publication number Publication date
IL272043A (en) 2020-03-31
EP3654983B1 (fr) 2023-08-30
US20200206226A1 (en) 2020-07-02
US11246870B2 (en) 2022-02-15
IL272043B (en) 2022-09-01
ES2963315T3 (es) 2024-03-26
NZ761505A (en) 2023-09-29
MY200803A (en) 2024-01-16
JP7220193B2 (ja) 2023-02-09
US20220160715A1 (en) 2022-05-26
EA202090266A1 (ru) 2020-06-05
KR102705858B1 (ko) 2024-09-10
KR20200029513A (ko) 2020-03-18
JP2020527137A (ja) 2020-09-03
US11738027B2 (en) 2023-08-29
AU2018304508B2 (en) 2021-06-10
CA3068910A1 (fr) 2019-01-24
EP3654983A1 (fr) 2020-05-27
SG11202000086PA (en) 2020-02-27
ZA202000904B (en) 2023-04-26
CN110891572B (zh) 2023-08-15
BR112019026270A2 (pt) 2020-06-30
AU2018304508A1 (en) 2020-02-27
CN110891572A (zh) 2020-03-17
WO2019016074A1 (fr) 2019-01-24

Similar Documents

Publication Publication Date Title
IL282304A (en) Topical pharmaceutical compositions
SI4037735T1 (sl) Naprava za dostavo zdravila
DK3984570T3 (da) Lægemiddelleveringsindretning
DK3565550T3 (da) Farmaceutiske sammensætninger omfattende meloxicam og rizatriptan
DK3703783T3 (da) Medicinafgivelsesanordning
DK3497086T3 (da) Aminopyrimidin-SSAO-inhibitorer
DK3703785T3 (da) Lægemiddelindgivelsesanordning
EP3905900C0 (fr) Formulation de nicotine liquide
EP3528737A4 (fr) Support médical
DK3634377T3 (da) Farmaceutisk formulering
MA49006A (fr) Inhibiteurs d'ip6k
DK3514153T3 (da) Pyrimidinforbindelse og farmaceutisk anvendelse deraf
EP3525841C0 (fr) Micro-dispositif d'administration
DK3796896T3 (da) Farmaceutisk adrenalinformulering
EP3600524C0 (fr) Adaptateur pour dispositif d'administration de médicament
EP3836921C0 (fr) Compositions pharmaceutiques liquides de bendamustine
DK3570911T3 (da) Medikamenttilførselsanordning
EP3603586A4 (fr) Dispositif de pose de stent
EP3583943A4 (fr) Composition pharmaceutique
MA49618A (fr) Inhibiteurs de la mpo destinés à être utilisés en médecine
DK3558427T3 (da) Lægemiddelfremføringsanordning
DK3449892T3 (da) Lægemiddeludleveringsapparat
PL3468535T3 (pl) Solubilizator resweratrolu do zastosowań farmaceutycznych
DK3694585T3 (da) Lægemiddelindgivelsesanordning
DK3681564T3 (da) Lægemiddeladministrationsanordning